Histologically confirmed recurrent adenocarcinoma of the prostate, clinical stage T1 - T3 (AJCC 6th Edition, see Appendix II), NX/N0, M0, following prior prostate radiotherapy.
Karnofsky performance status \>80.
Greater than 5 year life expectancy
Greater than 2 years since the original course of radiotherapy.
Absence of distant metastases by radiologic or pathologic assessment.
Absence of lymph node involvement by radiologic or pathologic assessment.
Patients must sign a study-specific informed consent form prior to study entry.
You may not be if
Stage T4 disease (AJCC 6th Edition, see Appendix II).
Less than 2 years since the original course of radiotherapy.
Lymph node involvement (N1).
Evidence of distant metastases (M1).
Radical surgery for carcinoma of the prostate
Previous or concurrent cancers other than basal, in situ, or squamous cell skin cancers unless disease-free for ≥ 5 years.
Major medical or psychiatric illness, which in the investigator's opinion, would prevent completion of treatment and would interfere with follow-up.
History of inflammatory bowel disease
Late GI or GU Morbidity \> Grade 1 from the prior course of radiotherapy
Clareo Health | CyberKnife Radiosurgery for Locally Recurrent Prostate CA
